ADEL AL-MOHAMADY
Jeddah,Saudi Arabia
Summary
Experienced managing director with a proven track record of leading companies to sustained growth and operational excellence. Skilled in strategic planning, stakeholder engagement, and financial management, Driving profitability and market expansion. Driving and building high-performing teams and building strong partnerships to enhance business value and business growth.
Overview
26
26
years of professional experience
Work history
CEO & Co Founder
WELPHAR Pharmaceuticals Gulf - UAE
, KSA
01.2018 - 11.2025
- Share engaged in the concept of the company shaping since 2017 with stockholders.
- Established the company in 2017
- Shaping the policy of the company and the strategies that the company will depend on.
- Defined the different therapeutic areas the company will invade .
- Did all Market surveys that defined the markets segments and market size to each item and market requirements.
- Developed the private label formulas that will be the best in each market segment targeting the market leader positioning.
- Finalised the manufacturing agreements with different Saudi Pharmaceutical Factories for local production to match “Saudi Made” concept by Saudi Government plus Finalised the distribution agreement with Ultra Pharma in Saudi Arabia and Finance control office in UAE “ Farahat Co” .
- Developed a comprehensive 5 years business plan and implemented business plans to achieve operational objectives.
- Hiring a selected professional marketing team.
- Business operation induction by Jan 2018 and Launched 1st wave of items of 5 items.
- Managing all business categories Sales, Marketing ,Planning , Production affairs, Business development and Finance.
- Sales achievement 2018 by 5M SAR .
- Increased brand recognition with innovative marketing campaigns.
- Led strategic initiatives to drive organisational growth and enhance market positioning.
- Penetration both Rx and OTC market in all key account customers in KSA like Al-Nahdi, Al-Dawaa, United Pharmacies and all other big chain pharmacies like Lemon, Nawa and Zahret Al-Rawda plus all potential hospitals and polyclinics like Dr. Soliman Fakeeh and Erfan and Soliman Al-Habeeb.
- Very high success from 2018 to 2024 by sales growth 20% annually
- Penetration to Tender market “NUPCO” in 2023 by locally produced topical items.
- Partnerships and co-operation with international companies their portfolio has FDA approval to penetrate other NUPCO segments like Laurus Labs company - India and Nanjing -China.
- Directed company-wide performance evaluations to assess effectiveness and implement improvements.
- Fostered a culture of innovation for product development success.
- Led strategic planning initiatives to secure company's future growth.
- Financial management processes ensuring sustainable profitability and fiscal responsibility.
- Introduced cost control measures, witnessed significant reduction in overheads.
Managing Director
Dendron Brands Ltd , UK
, SAUDI ARABIA
01.2010 - 12.2017
- Managed a sales budget of 10 M SAR .
- Boosted market penetration by 20% the new items and other Dentinox forms by 30% sales growth annually by developing and executing targeted sales strategies for baby formulas, like , Dentinox Teething gel, Nossal range.
- Modify marketing strategy for the underweight item ,Super Wate On as reflected in double growth rate annually.
- Establishing marketing & Sales skilful team that performed the 30% growth annually.
- Boosted the company profitability to get annual 30% net profit for stockholders.
- Pharmaceutical company for Infant and baby product range/ Dentinox
Sales Manager
MARNYS , SPAIN
, Saudi Arabia
07.2008 - 12.2009
- Increased annual sales revenues by double figures as incresed the sales value from 32M SAR to 52M SAR By improving the sales & market share of company Items at the key account customers like Alnahdi & Aldawaa and united pharmacies by 20 M SAR in 2 years consistent annual growth.
- Launched a first item of L Arginine as a NO precursor for improving the effect of PDE5 inhibitors for ED in Men.
- Food supplement & Nutraceutical company
Field Supervisor
LIPTIS Pharma , UAS
, Saudi Arabia
03.2004 - 06.2008
- Launch of 1st item concerning Male sexual desire Gentaplex and leading mfor marketing team for consistent business growth by 15% annualy.
- Spearheaded launch of Gentaplex, increasing new concept for Andrologists in KSA and contributing 70% of Middle East sales through strategic marketing leadership.
- American Pharmaceutical Company
Senior Medical Representative
MARNYS , SPAIN
, SAUDI ARABIA
03.2003 - 02.2004
- Improved sales and customer satisfaction for Nutraceutical items by streamlining communication with key account customers and improved the processes across marketing department for annual business growth by 30%.
- Shared in successful launches for new items that became market leaders in Saudi Arabia.
- Spanish Food supplement & Nutraceutical company
Executive Medical Representative
Merck Sharp & Dhome -USA
, EGYPT
10.1999 - 02.2003
- Performing highly efficient launches for Vioxx and Fosamax weekly form with annual consistent growth by 20% and keeing high market share by 10 %.
- Coordinated a cross-functional team of marketing members to deliver sales and market share annually.
- Pharmaceutical Company
Education
Bachelor's degree - Medicine
Faculty Of Vet Medicine
EgyptSkills
- Your Skill
- Operations Management
- Strategic Planning
- Business Development
- Sales Management
- Product Development
- Team Leadership
- Financial Management
- Leadership
- Stakeholder Engagement
- Decision Making
- Negotiation
- Visionary Thinking
- Marketing Strategy
- Communication
- Business restructuring
- Resilience and stamina
Training / Courses
- Professional MBA
- Marketing Management
- Sales Management
Languages
Arabic
Native
English
Advanced
Timeline
CEO & Co Founder
WELPHAR Pharmaceuticals Gulf - UAE
01.2018 - 11.2025
Managing Director
Dendron Brands Ltd , UK
01.2010 - 12.2017
Sales Manager
MARNYS , SPAIN
07.2008 - 12.2009
Field Supervisor
LIPTIS Pharma , UAS
03.2004 - 06.2008
Senior Medical Representative
MARNYS , SPAIN
03.2003 - 02.2004
Executive Medical Representative
Merck Sharp & Dhome -USA
10.1999 - 02.2003
Bachelor's degree - Medicine
Faculty Of Vet Medicine